Portfolio | Healthcare/Life Sciences

BioRexis is developing protein and peptide drugs with superior half-life and pharmacokinetic profiles. The company’s protein engineering technology uses a natural variant of the human blood serum protein transferrin as a carrier protein and as a scaffold for the effective delivery of proteins and peptides.
Cerionx (formerly Microplate Automation) has developed a new, patented technology and process that uses low temperature, atmospheric pressure plasma to clean and sterilize highly sensitive equipment, such as pharmaceutical and biotechnology laboratory equipment.
GlycoMimetics is capitalizing on recent advances in glycobiology by developing small molecule drugs that mimic the actions of carbohydrates. The company is focusing its initial efforts on therapeutics to treat inflammatory diseases such as cystic fibrosis and cancer.
HTH Worldwide is the leading provider of health insurance to international students attending U.S. universities and an innovator in online healthcare information, medical assistance and insurance services for travelers around the globe.
Immune Control is an early-stage drug discovery company that has developed novel approaches to immune modulation using small molecule, serotonin antagonists.

Immunicon (IMMC, NASDAQ) has developed a revolutionary diagnostic platform based on immuno-magnetic selection and fluorescent characterization of rare cells in blood. The company’s initial products diagnose and monitor cancer.

Ion Healthcare is introducing a new approach to identifying and managing patients suffering from obstructive sleep apnea (OSA). Ion utilizes a proprietary FDA approved portable sleep apnea diagnostic system and provides CPAP and disease management programs to OSA patients in the Mid-Atlantic.

Nucleonics has developed a proprietary method of RNA interference to silence disease-causing genes. Initially, the company is applying its technology to develop expressed interfering RNA (eiRNA) therapies for the treatment of chronic Hepatitis B and Hepatitis C viral infections.
Sensors for Medicine and Science has developed a portfolio of patented and highly sensitive fluorescence molecular sensing technologies. The company is commercializing two product suites: a minimally invasive glucose monitor for diabetics and an oxygen sensor to measure metabolic rate.